Table 3.
Characteristics of patients with early arthritis with erosive and non-erosive disease
| Erosive, n=17 | Non-erosive, n=33 | p Value | |
|---|---|---|---|
| Age, years | 54 (24–81) | 46 (20–75) | 0.92 |
| Disease duration, months | 6 (1–11) | 5 (1–12) | 0.39 |
| DAS28 | 3.7 (1.1–5.7) | 2.4 (0.6–6.3) | 0.012 |
| ESR, mm/h | 36 (3–91) | 32 (9–93) | 0.72 |
| CRP, mg/litre | 14 (1–114) | 10 (1–133) | 0.68 |
| VAS, 0–100 | 42 (11–81) | 38 (3–98) | 0.88 |
| IgM-RF positive, % | 35 | 21 | 0.32 |
| ACPA positive, % | 24 | 27 | 0.88 |
ACPA, anti-citrullinated protein antibody; CRP, C-reactive protein; DAS28, 28-joint Disease Activity Score; ESR, erythrocyte sedimentation rate; IgM-RF, immunoglobulin M rheumatoid factor; VAS, visual analogue scale of global disease activity.